Synthesis of BILN 2061, an HCV NS3 Protease Inhibitor with Proven Antiviral Effect in Humans
- 21 July 2004
- journal article
- research article
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 6 (17) , 2901-2904
Abstract
The synthesis of BILN 2061, an NS3 protease inhibitor with proven antiviral effect in humans, was accomplished in a convergent manner from four building blocks. The procedure described here was suitable for the preparation of multigram quantities of BILN 2061 for preclinical pharmacological evaluation.Keywords
This publication has 27 references indexed in Scilit:
- Molybdenum and Tungsten Imido Alkylidene Complexes as Efficient Olefin‐Metathesis CatalystsAngewandte Chemie International Edition, 2003
- Macrocyclic Inhibitors of the NS3 Protease as Potential Therapeutic Agents of Hepatitis C Virus InfectionAngewandte Chemie International Edition, 2003
- 136 Antiviral effect of BILN 2061, a novel HCV serine protease inhibitor, after oral treatment over 2 days in patients with chronic hepatitis C, non-genotype 1Hepatology, 2003
- Olefin Metathesis-Active Ruthenium Complexes Bearing a Nucleophilic Carbene LigandJournal of the American Chemical Society, 1999
- Highly Regio- and Enantioselective Catalytic Hydrogenation of Enamides in Conjugated Diene Systems: Synthesis and Application of γ,δ-Unsaturated Amino AcidsJournal of the American Chemical Society, 1998
- A Mild Amide to Carbamate TransformationThe Journal of Organic Chemistry, 1997
- A Practical Enantioselective Synthesis of .alpha.-Amino Dicarboxylates. Preparation of D- and L-.alpha.-Aminoadipate, -.alpha.-Aminopimelate, and -.alpha.-AminosuberateThe Journal of Organic Chemistry, 1994
- Isolation of a cDNA cLone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis GenomeScience, 1989
- Synthesis of (R)-6-methyltryptophan via enantioselective catalytic hydrogenationThe Journal of Organic Chemistry, 1979
- On the size of the active site in proteases. I. PapainBiochemical and Biophysical Research Communications, 1967